16–21 Sept 2012
Como, Italy
Europe/Rome timezone

ORAL PRESENTATION - Exploration of the metallic character of astatine

18 Sept 2012, 10:55
15m
Como, Italy

Como, Italy

Grand Hotel di Como Via per Cernobbio 41A 22100 Como, Italy
Oral Communications Chemistry of radioelements and Super Heavy Elements research Session 3 - Chemistry of radioelements and Super Heavy Elements research

Speaker

Gilles Montavon (Subatech, France)

Description

Astatine 211 is considered to be one of the most promising candidates for targeted alpha therapy (TAT)1, 2 and it is the subject of a wide research program in Nantes (France). Very few data on the chemistry of astatine (At) are available. On the one hand, At is a rare element and it has only short half-life radioactive isotopes. On the other hand, it is an “invisible” element: the amount of At-211 produced allows working at ultra trace concentrations (typically 10-11 to 10-15 M) and no spectroscopic techniques can be used to estimate At characteristics at the molecular level. As a result, At chemistry is not well understood. Based on these considerations, a research program has started in Nantes to explore the fundamental properties of At using a multi-disciplinary approach combining radiochemistry, analytical chemistry and molecular modelling competences. The object of this contribution is to present the main advances obtained during the last 8 years as regards especially to the particular metallic character of astatine. The methodology enabled us to define a Pourbaix diagram (Eh/pH diagram) for At in non-complexing acidic aqueous medium. We showed the existence of At-, and two stable At+ and AtO+ metallic forms of astatine.3, 4 This highlighted the metallic character of At by comparison with others halogens, as it was already proposed in the 60’s.5 Our recent results on the chemical reactivity of AtO+ demonstrate the potentiality to form both coordination and covalent bondswith organic and inorganic ligands.6, 7 1. D. S. Wilbur, Current Radiopharmaceuticals, 2008, 3, 144-176. 2. M. R. Z. Vaidyanathan G., Current Radiopharmaceuticals, 2008, 1, 177-196. 3. J. Champion, C. Alliot, E. Renault, B. M. Mokili, M. Cherel, N. Galland and G. Montavon, The Journal of Physical Chemistry A, 2010, 114, 576-582. 4. A. Sabatié-Gogova, F. Pottier, J. Champion, S. Huclier, N. Michel, N. Galland, Z. Asfari, M. Chérel and M. G., Analytical Chimica acta, 2012, 721, 182. 5. E. H. Appelman, J. Am. Chem. Soc., 1961, 83, 805-807. 6. J. Champion, C. Alliot, S. Huclier, D. Deniaud, Z. Asfari and G. Montavon, Inorganica Chimica Acta, 2009, 362, 2654-2661. 7. J. Champion, M. Seydou, A. Sabatie-Gogova, E. Renault, G. Montavon and N. Galland, Physical Chemistry Chemical Physics, 13, 14984-14992.

Author

Gilles Montavon (Subatech, France)

Co-authors

Dr Andréa Sabatié-Gogova (SUBATECH, UMR CNRS 6457 IN2P3 Université et Ecole des Mines de Nantes, 4 rue A. Kastler, 44307 Nantes, France) Dr Cyrille Alliot (ARRONAX, 1, rue Aronnax - 44817 SAINT-HERBLAIN, France) Dr Eric Renault (CEISAM, UMR CNRS 6230, Université de Nantes, 2 Rue de la Houssinière, 44322 Nantes, France) Mr Fadel Bassal (CEISAM, UMR CNRS 6230, Université de Nantes, 2 Rue de la Houssinière, 44322 Nantes, France) Dr Julie Champion (SUBATECH, UMR CNRS 6457 IN2P3 Université et Ecole des Mines de Nantes, 4 rue A. Kastler, 44307 Nantes, France) Dr Nicolas Galland (CEISAM, UMR CNRS 6230, Université de Nantes, 2 Rue de la Houssinière, 44322 Nantes, France) Dr Tahra Ayed (CEISAM, UMR CNRS 6230, Université de Nantes, 2 Rue de la Houssinière, 44322 Nantes, France)

Presentation materials

There are no materials yet.